Trigger finger Musculoskeletal Diseases
Conditions
Interventions
Eligible participants will be randomly assigned to either the control or intervention groups in a 1:1 ratio. The allocation sequence will be concealed from the researcher and patients using sequential
Sponsors
Prince of Wales Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Trigger finger patients aged 18 years and over 2. Trigger finger patients with single finger digit problem at presentation 3. Trigger finger patients have corticosteroid injections and are fit for discharge at the subsequent follow-up visit
Exclusion criteria
Exclusion criteria: 1. Patients who do not have a smartphone 2. Patients with no internet access 3. Patients who cannot read Chinese
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility of the trial will be measured in terms of: 1. Percentage of eligible patients recruited: the percentage of patients that are eligible to participate in the study among all those approached for the study during the recruitment period. 2. Recruitment rate and time: recruitment rate is defined by the percentage of patients recruited for the study among all those eligible for the study. Recruitment time is the time needed to recruit the requested sample size. 3. Exercise log response and compliance rate: an online exercise log will be sent to participants weekly at 1, 2, 3, 4, 8, 12, 16 and 20 weeks post baseline. It requests patients to have recalled exercise entries for the past 1 week. Exercise log response rate is the percentage of online exercise log submitted and compliance rate is the percentage of exercise entries recorded. 4. Follow-up rate: the percentage of participants who have submitted the online survey at 6 months among all those who participated in the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| The preliminary effectiveness of the finger gliding exercise collected via an online questionnaire at 6 months: 1. Self-rated change of finger condition measured by asking patients to indicate whether they have improved, no change or worsening symptoms 2. Overall finger pain severity measured by Numerical Pain Rating Scale (NPRS) 3. Severity of symptoms measured using Quinelle grading 4. Number of repeated injections: participants will report whether there has been a repeated injection of the trigger finger being studied from baseline until the time of answering the questionnaire 5. The occurrence of a new trigger finger site: participants will report whether there is emergence of a new trigger finger site besides the trigger finger being studied from baseline until the time of answering the questionnaire | — |
Countries
Hong Kong
Contacts
Public ContactYue Kwan Choi
Outcome results
None listed